NIH recently updated its annual categorical information with fiscal year (FY) 2022 actual spending data and estimates for FY 2023 and 2024. Available on the Research, Condition, and Disease Categorization (RCDC) page, you will find the annual support level for various research, condition, and disease categories. The data are based on grants, contracts, and other funding mechanisms used across NIH.
There were 215 public categories when RCDC information began being reported in 2008. Now in our fifteenth year, there are a total of 315 categories. The following new categories were added in FY 2022:
- Cocaine
- PASC (Post-Acute Sequelae of SARS-CoV-2), including Long COVID
- Polycystic Ovary Syndrome (PCOS)
- Pulmonary Fibrosis
- Pulmonary Hypertension
- Sarcoidosis
- Stimulant Use and Misuse
There were also several existing categories that were renamed including:
- Migraines renamed to Migraine
- Prescription Drug Abuse renamed to Prescription Drug Misuse
- Screening and Brief Intervention for Substance Abuse renamed to Screening and Brief Intervention for Substance Misuse
- Substance Abuse Prevention renamed to Substance Misuse Prevention
For more background on RCDC, please see this NIH Open Mike blog and the RCDC process here.
0 Comments